Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
Federal Reserve Vice Chair Richard Clarida said Friday that the global economy has deteriorated in the past month.Marketsread more
The latest escalation in the trade war ups the odds the economy will fall into recession and that the Fed will aggressively cut rates.Market Insiderread more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
"We don't need China and, frankly, would be far better off without them," Trump tweeted.Politicsread more
"My only question is, who is our bigger enemy, Jay Powell or Chairman Xi?" Trump wrote amid a series of tweets that rattled markets Friday.Politicsread more
"I would love this to be clarified. We come to a deal on trade, boy, this market is up 10 to 15%, but without it's going to be worrisome," Jeremy Siegel says.Marketsread more
The final week of August could be highly volatile as markets fret over the economy and the latest developments in trade wars.Market Insiderread more
Tesla solar energy systems reportedly ignited at an Amazon warehouse in Redlands, California last June, and the Seattle e-commerce titan confirmed that it has no further plans...Technologyread more
The death comes as federal and state health officials investigate a slew of lung illnesses in connection to e-cigarette use.Health and Scienceread more
Health officials are in a different position to respond to the current Ebola outbreak than they were during the last one, U.S. Food and Drug Administration Commissioner Scott Gottlieb told CNBC's "Squawk Box" on Tuesday.
Democratic Republic of Congo has 39 suspected, probable and confirmed cases of Ebola since April, including 19 deaths, the World Health Organization said Monday. The country agreed to allow the WHO to administer Merck's experimental Ebola vaccine.
An outbreak in West Africa in 2014 was the deadliest occurrence of the disease since it was discovered in 1976, killing more than 11,300 people, according to the WHO.
The FDA is monitoring this situation "very closely," Gottlieb told CNBC, but health officials are "in a very different posture" than last time.
"I think the world is more galvanized, the WHO has stepped in very aggressively and very early," he said. "We have therapeutics available right now, including the potential for a vaccine, so we're differently armed than the last time we had a global crisis related to Ebola."
"That said, this is a scary infection and we're monitoring it very closely."